• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Equity | News | Hot Pursuit
Hot Pursuit
SPARC gains after research collaboration with HitGen
(09:23, 13 Mar 2019)
The announcement was made before market hours today, 13 March 2019.

Meanwhile, the S&P BSE Sensex was down 6.33 points, or 0.02% to 37,529.33.

On the BSE, 11,000 shares were traded in the counter so far compared with average daily volumes of 2.46 lakh shares in the past two weeks. The stock had hit a high of Rs 200 and a low of Rs 197.50 so far during the day. The stock hit a 52-week high of Rs 438.25 on 24 April 2018. The stock hit a 52-week low of Rs 140.95 on 6 February 2019.

Sun Pharma Advanced Research Company (SPARC) and HitGen announced a research collaboration to identify novel small molecule leads for targets of interest. Under this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for SPARC. Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments.

HitGen is a rapidly growing biotech company with headquarters and main research facilities based in Chengdu, China and with a subsidiary in the USA.

Sun Pharma Advanced Research Company reported net loss of Rs 69.02 crore in Q3 December 2018 as against net loss of Rs 58.07 crore in Q3 December 2017. Net sales rose 2.37% to Rs 19.88 crore in Q3 December 2018 over Q3 December 2017.

Sun Pharma Advanced Research Company (SPARC) is a global pharmaceutical company focused on continuously improving standards of care for patients globally through innovation in therapeutics and delivery.

Powered by Capital Market - Live News

SEBI Regn. No: NSE : INB 230643233/TM06432, INE 230643233(CD), INF 230643233 (F&O) BSE : INB 10643238/TM3129, INE 10643238(cd), INF 10643238(F&O)
SEBI Regn. No: MCX/ NCDEX: INZ000028833, NCDEX : NCDEX/TCM/CORP/0460 | MCX : MCX/TCM/CORP/0263 | CDSL : IN-DP-CDSL-266-2004 MCX-SX:INE 260643233/21500(CD)
Investor Grievances Email ID: compliance@dbonline.in & investors@dbonline.in
Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries